I'm going to have to say my glass is half full, but I admit that I haven't experienced the disappointments many here have suffered through.  I only started looking at this stock a few months ago before the run-up into the Pennsaid 2% PDUFA.  I started buying after the CRL.

Honesly, after researching the history of Zars, Pliaglis is what compelled me to buy this stock.  I am also hoping it outsells Pennsaid.  I feel like Nuvo may have these same hopes, but management knows they are on thin ice.  They can't jump and give an optimistic outlook, or else they risk crashing through the ice when they land.